• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Emergency

Lower blood transfusion threshold in septic shock safe at 90-days

byJon LiuandXu Gao
June 8, 2022
in Emergency, Infectious Disease, The Classics
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Patients with septic shock requiring critical care and transfused to a lower hemoglobin threshold had similar rates of mortality at 90-days after randomization as compared to those transfused to a higher threshold.

2. A lower hemoglobin threshold conserves resources with fewer total blood transfusions and no difference in use of vasopressors, mechanical ventilation and renal replacement therapy.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Despite various guidelines, practices regarding the threshold for blood transfusion in the setting of septic shock continue to vary, largely due to unequivocal evidence. This multi-centered, partially-blinded trial randomized septic shock patients in the critical care setting to low (>70 g/dL) or high (>90 g/dL) hemoglobin transfusion threshold. The results revealed no significant change in mortality at 90-days after randomization. Furthermore, there were no statistically significant differences in all secondary endpoints, which included use of life supporting measures, ischemic events, and severe adverse reactions.

Screening for cardiovascular events in this study was not part of the transfusion protocol as this decision was clinically-driven. Therefore, myocardial ischemia may not have been detected in all enrolled patients and these results may not be generalizable to those with a significant history of cardiovascular disease. However, the results of this study were consistent with similar past studies currently cited in guidelines for sepsis management (i.e., TRICC, FOCUS). A lower hemoglobin transfusion threshold also reduced the number of total blood transfusions and the number of patients who were able to avoid any transfusion. Future studies will likely be powered to identify safe transfusion thresholds for specific subgroups identified by this study (i.e. septic shock patients with significant cardiovascular comorbidities).

Click to read the study, published today in NEJM

RELATED REPORTS

Minimally invasive surgery is beneficial for epithelial ovarian cancer 

#VisualAbstract: Tarlatamab Improves Survival in Small-Cell Lung Cancer after Platinum-Based Chemotherapy

Intravaginal conjugated oestrogen does not improve continuation rate of ring pessary use

Click to read an accompanying editorial in NEJM

Relevant Reading: Liberal or Restrictive Transfusion in High-Risk Patients after Hip Surgery

In-Depth [randomized controlled trial]: 1005 patients with septic shock requiring intensive care admission were randomized into two groups: low (>70 g/dL) or high (>90 g/dL) hemoglobin transfusion thresholds. Both groups were well-matched for baseline characteristics including age, source of sepsis, and interval from ICU admission to randomization. The primary endpoint of mortality at 90-days after randomization was achieved in 43% versus 45% (low versus high, p=0.44). There was also a significant reduction in the number of blood transfusions (low versus high, 1545 v. 3088, p<0.001) and patients who did not receive any transfusions (low versus high, 176 v. 6, p<0.001). Subgroup analysis for age, presence of chronic cardiovascular disease and SAPSII score at baseline did not demonstrate any significant difference between the two groups (p=0.85, p=0.25, p=0.06, respectively).

More from this author: Brodalumab effective in treating active psoriatic arthritis, Idelalisib plus rituximab improves progression-free survival in relapsed CLL, SSRI use during pregnancy not linked to increased risk of autism, Combo antifungal therapy most effective treatment for cryptococcal meningitis

Image: PD

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

Previous Post

Modifiable lifestyle factors may halve risk of gestational diabetes

Next Post

Evolocumab significantly reduces LDL cholesterol in familial hypercholesterolemia patients [TESLA-B and RUTHERFORD-2 studies]

RelatedReports

All Specialties

Minimally invasive surgery is beneficial for epithelial ovarian cancer 

July 4, 2025
#VisualAbstract: Tarlatamab Improves Survival in Small-Cell Lung Cancer after Platinum-Based Chemotherapy
StudyGraphics

#VisualAbstract: Tarlatamab Improves Survival in Small-Cell Lung Cancer after Platinum-Based Chemotherapy

July 4, 2025
American Academy of Pediatrics recommends standards for adverse event disclosures
Chronic Disease

Intravaginal conjugated oestrogen does not improve continuation rate of ring pessary use

July 3, 2025
Pediatric DKA associated with recent acute care visits
Chronic Disease

Artificial intelligence based clinical decision systems are safe and effective for diabetes management

July 3, 2025
Next Post
Low circulating cholesterol in neonates linked with pyloric stenosis

Evolocumab significantly reduces LDL cholesterol in familial hypercholesterolemia patients [TESLA-B and RUTHERFORD-2 studies]

Elective neck dissection may be unnecessary for adenoid cystic carcinoma

Elective neck dissection may be unnecessary for adenoid cystic carcinoma

Many lung cancers visible on prior imaging studies

Low dose CT screening may detect early lung cancers: the NELSON trial

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Minimally invasive surgery is beneficial for epithelial ovarian cancer 
  • #VisualAbstract: Tarlatamab Improves Survival in Small-Cell Lung Cancer after Platinum-Based Chemotherapy
  • Intravaginal conjugated oestrogen does not improve continuation rate of ring pessary use
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.